Cost-Effectiveness Analysis of Spending on Research and Development to Address the Needs for Innovative Therapeutic Products in Indonesia

References

• Health Sciences Authority. Regulatory overview of therapeutic products. Available from: https://www.hsa.gov.sg/therapeutic-products/overview. Accessed April 10, 2020.
   Google Scholar
• UNESCO Institute for Statistics. Science, Technology and Innovation. Available from: http://data.uis.unesco.org/#. Accessed June 10, 2020.
   Google Scholar
• Xu X, Zhang L, Chen L, Wei F. Does COVID-2019 have an impact on the purchase intention of commercial long-term care insurance among the elderly in China? Healthcare. 2020;8(2):126.
   Web of Science ®Google Scholar
• Xu X, Chen L. Projection of long-term care costs in china, 2020–2050: based on the bayesian quantile regression method. Sustainability. 2019;11:3530. doi:10.3390/su11133530
   Web of Science ®Google Scholar
• Xu X, Huang X, Zhang X, Chen L. Family economic burden of elderly chronic diseases: evidence from China. Healthcare. 2019;7:99. doi:10.3390/healthcare7030099
   Web of Science ®Google Scholar
• Chen L, Zhang X, Xu X. Health insurance and long-term care services for the disabled elderly in china: based on charls data. Risk Manag Healthc Policy. 2020;13:155–162. doi:10.2147/RMHP.S233949
   PubMed Web of Science ®Google Scholar
• DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development cost. J Health Econ. 2003;22:151–185. doi:10.1016/S0167-6296(02)00126-1
   PubMed Web of Science ®Google Scholar
• Xu X, Xu Z, Chen L, Li C. How does industrial waste gas emission affect health care expenditure in different regions of china: an application of bayesian quantile regression. Int J Environ Res Public Health. 2019;16(15):2748. doi:10.3390/ijerph16152748
   PubMed Web of Science ®Google Scholar
• Daemmrich A, Mohanty A. Healthcare reform in the United States and China: pharmaceutical market implications. J Pharm Policy Pract. 2014;7(1):1–13. doi:10.1186/2052-3211-7-9
   PubMedGoogle Scholar
• World Bank. World development indicators. Available from: http://wdi.worldbank.org/tables. Accessed April 10, 2020.
   Google Scholar
• World Bank. Indonesia – Supporting Primary Healthcare Reform Project: Technical Assessment (English). Washington DC: World Bank Group; 2018.
   Google Scholar
• WHO SEARO. The Republic of Indonesia Health System Review. New Delhi: WHO; 2017.
   Google Scholar
• Institute for Scientific Information. The Annual G20 Scorecard research Performance 2019. Available from: https://clarivate.com/webofsciencegroup/campaigns/the-annual-g20-scorecard-research-performance-2019/. Accessed April 5, 2020.
   Google Scholar
• Han E, Chae SM, Kim NS, Park S. Effects of pharmaceutical cost containment policies on doctors’ prescribing behavior: focus on antibiotics. Health Policy (New York). 2015;119(9):1245–1254. doi:10.1016/j.healthpol.2015.05.005
   Web of Science ®Google Scholar
• Bae G, Park C, Lee H, Han E, Kim DS, Jang S. Effective policy initiatives to constrain lipid-lowering drug expenditure growth in South Korea. BMC Health Serv Res. 2014;14:100. doi:10.1186/1472-6963-14-100
   PubMed Web of Science ®Google Scholar
• Cho MH, Yoo KB, Lee HY, et al. The effect of new drug pricing systems and new reimbursement guidelines on pharmaceutical expenditures and prescribing behavior among hypertensive patients in Korea. Health Policy (New York). 2015;119(5):604–611. doi:10.1016/j.healthpol.2015.01.002
   Web of Science ®Google Scholar
• Ministry of Health, Republic of Indonesia. Strategic plan 20202024. Available from: https://www.kemkes.go.id/resources/download/info-terkini/Rakerkesnas-2020/. Accessed March 30, 2020.
   Google Scholar
• Boer FP. The Valuation of Technology: Business and Financial Issues in R&D, Operations Management Series for Professionals. New York: John Wiley; 1999.
   Google Scholar
• CNN Indonesia. Indonesia Research Budget; 2020. Available from: https://www.cnnindonesia.com/teknologi/20200128122325-199-469363/anggaran-riset-dan-pengabdian-masyarakat-2020-capai-rp146-t. Accessed April 10, 2020.
   Google Scholar
• Jayasundara K, Hollis A, Krahn M, et al. Estimating the clinical cost of drug development for orphan versus non-orphan drugs. Orphanet J Rare Dis. 2019;14(1):12. doi:10.1186/s13023-018-0990-4
   PubMed Web of Science ®Google Scholar
• Jakovljevic MB. BRIC’s growing share of global health spending and their diverging pathways. Front Public Health. 2015;3:135. doi:10.3389/fpubh.2015.00135
   PubMed Web of Science ®Google Scholar
• Jakovljevic M, Getzen TE. Growth of global health spending share in low and middle income countries. Front Pharmacol. 2016;7:21. doi:10.3389/fphar.2016.00021
   PubMed Web of Science ®Google Scholar
• Wirtz VJ, Hogerzeil HV, Gray AL, et al. Essential medicines for universal health coverage. Lancet. 2017;389:403–476. doi:10.1016/S0140-6736(16)31599-9
   PubMed Web of Science ®Google Scholar
• Wagner AK, Graves AJ, Reiss SK, et al. Access to care and medicines, burden of health care expenditures, and risk protection: results from the world health survey. Health Policy (New York). 2011;100:151–158. doi:10.1016/j.healthpol.2010.08.004
   PubMed Web of Science ®Google Scholar
• Hill AM, Barber MJ, Gotham D. Estimated costs of production and potential prices for the WHO essential medicines list. BMJ Glob Health. 2018;3:e000571. doi:10.1136/bmjgh-2017-000571
   PubMed Web of Science ®Google Scholar
• Fortunak JM, de Souza RO, Kulkarni AA, et al. Active pharmaceutical ingredients for antiretroviral treatment in low- and middle-income countries: a survey. Antivir Ther. 2014;19(Suppl 3):15–29. doi:10.3851/IMP2897
   PubMed Web of Science ®Google Scholar
• Basu P, Joglekar G, Rai S, et al. Analysis of manufacturing costs in pharmaceutical companies. J Pharm Innov. 2008;3:30–40. doi:10.1007/s12247-008-9024-4
   Google Scholar
• World Health Organization. The world medicines situation. Available from: http://apps.who.int/medicinedocs/pdf/s6160e/s6160e.pdf. Accessed March 2, 2020.
   Google Scholar
• UN Secretary-General. The United Nations secretary-general’s high-level panel on access to medicines report: promoting innovation and access to health technologies; [cited 2020 April 1]. Available from: http://www. unsgaccessmeds.org/s/UNSG- HLP- Report- FINAL- 12- Sept- 2016. Pdf. Accessed April 2, 2020.
   Google Scholar
• The Jakarta Post. Pharma companies still dependent on imported APIs, says ministry. Available from: https://www.thejakartapost.com/news/2018/10/18/pharma-companies-still-dependent-on-imported-apis-says-ministry.html. Accessed April 2, 2020.
   Google Scholar
• Indonesia Investments. Pharmaceutical Exports Indonesia Remain Under Pressure in 2017. Available from: https://www.indonesia-investments.com/business/business-columns/pharmaceutical-exports-indonesia-remain-under-pressure-in-2017/item7867. Accessed April 2, 2020.
   Google Scholar
• Simanjuntak DG, Tjandrawinata RR. A study on influencers of total sales revenue of generic pharmaceutical companies in Indonesia. MPRA. 2011. 31628:111. Available from: https://mpra.ub.uni-muenchen.de/31628/. Accessed September 4, 2020.
   Google Scholar
• LEAD Innovation Management. The 4 phases of innovation. Available from: https://www.lead-innovation.com/english-blog/the-4-phases-of-innovation. Accessed April 2, 2020.
   Google Scholar
• DiMasi JA, Grabowski HG, Hansen RW. Innovation in the pharmaceutical industry: new estimates of R&D costs. J Health Econ. 2016;47:20–33. doi:10.1016/j.jhealeco.2016.01.012
   PubMed Web of Science ®Google Scholar
• International Federation of Pharmaceutical Manufacturers & Associations. The pharmaceutical industry and global health, facts and figures 2017. Available from: https://www.ifpma.org/wp-content/uploads/2017/02/IFPMA-Facts-And-Figures-2017.pdf. Accessed April 5, 2020.
   Google Scholar
• Carayannis EG, Campbell DFJ. ‘Mode 3ʹ and ‘quadruple helix’: toward a 21st century fractal innovation ecosystem. Int J Technol Manage. 2009;46(3/4):201–234. doi:10.1504/IJTM.2009.023374
   Web of Science ®Google Scholar
• Armas EB, Osorio CG, Moreno-Dodson B, Abriningrum DE. Agriculture public spending and growth in indonesia. Policy research working paper; no. WPS 5977. World Bank. 2012.Available from: https://openknowledge.worldbank.org/handle/10986/3263. Accessed September 4, 2020.
   Google Scholar
• Siagian RC, Ayuningtyas D. Gap analysis for drug development policy-making: an attempt to close the gap between policy and its implementation. PLoS One. 2019;14(8):e0220605. doi:10.1371/journal.pone.0220605
   PubMed Web of Science ®Google Scholar
• Rottingen JA, Regmi S, Eide M, et al. Mapping of available health research and development data: what’s there, what’s missing, and what role is there for a global observatory? Lancet. 2013;382:1286–1307. doi:10.1016/S0140-6736(13)61046-6
   PubMed Web of Science ®Google Scholar
• WHO. Research and development to meet health needs in developing countries: strengthening global financing and coordination. Available from: https://apps.who.int/iris/bitstream/handle/10665/254706/9789241503457-eng.pdf;jsessionid=D7D1D78319B6D54CD9AFAE78FA5DCECD?sequence=1. Accessed September 4, 2020.
   Google Scholar
• Cole CB, Trolle S, Edwards DJ. Developing the latest framework to measure and incentivise pharmaceutical industry contributions to health research and development. Health Res Policy Syst. 2018;16(1):73. doi:10.1186/s12961-018-0332-y
   PubMed Web of Science ®Google Scholar
• Leydesdorff L The knowledge-based economy and the triple helix model. Available from: https://www.leydesdorff.net/arist09/arist09.pdf. Accessed April 2, 2020.
   Google Scholar
• WHO. Country Pharmaceutical Situations, Fact Book on WHO Level 1 Indicators 2007. Geneve: WHO; 2009.
   Google Scholar
• Suwantika AA, Postma MJ. Effect of breastfeeding promotion interventions on cost-effectiveness of rotavirus immunization in Indonesia. BMC Public Health. 2013;13(1):1106. doi:10.1186/1471-2458-13-1106
   PubMed Web of Science ®Google Scholar
• Jakovljevic MB, Milovanovic O. Growing burden of non-communicable diseases in the emerging health markets: the case of BRICS. Front Public Health. 2015;3:65. doi:10.3389/fpubh.2015.00065
   PubMed Web of Science ®Google Scholar
• Jakovljevic M, Jakab M, Gerdtham U, et al. Comparative financing analysis and political economy of noncommunicable diseases. J Med Econ. 2019;22(8):722–727. doi:10.1080/13696998.2019.1600523
   PubMed Web of Science ®Google Scholar
• Morel CM, Acharya T, Broun D, et al. Health innovation networks to help developing countries address neglected diseases. Science. 2005;309(5733):401–404. doi:10.1126/science.1115538
   PubMed Web of Science ®Google Scholar
• Jakovljevic M, Groot M, Souliotis K. Editorial: health care financing and affordability in the emerging global markets. Front Public Health. 2016;4:2.
   PubMed Web of Science ®Google Scholar
• Jakovljevic MM. Comparison of historical medical spending patterns among the BRICS and G7. J Med Econ. 2016;19(1):70–76. doi:10.3111/13696998.2015.1093493
   PubMed Web of Science ®Google Scholar
• Jakovljevic M, Timofeyev Y, Ekkert NV, et al. The impact of health expenditures on public health in BRICS nations. J Sport Health Sci. 2019;8(6):516–519. doi:10.1016/j.jshs.2019.09.002
   PubMed Web of Science ®Google Scholar